Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Oxcarbazepine as an adjunct of antipsychotic therapy in acute schizophrenia

Trial Profile

Oxcarbazepine as an adjunct of antipsychotic therapy in acute schizophrenia

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 01 Jan 2009

At a glance

  • Drugs Oxcarbazepine (Primary)
  • Indications Psychotic disorders; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 01 Jan 2009 Primary endpoint 'Additional-treatment-required' has not been met.
    • 07 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top